ATE469642T1 - Vorbeugungs- oder heilmittel gegen endometriose - Google Patents

Vorbeugungs- oder heilmittel gegen endometriose

Info

Publication number
ATE469642T1
ATE469642T1 AT01271228T AT01271228T ATE469642T1 AT E469642 T1 ATE469642 T1 AT E469642T1 AT 01271228 T AT01271228 T AT 01271228T AT 01271228 T AT01271228 T AT 01271228T AT E469642 T1 ATE469642 T1 AT E469642T1
Authority
AT
Austria
Prior art keywords
endometriosis
preventive
cure
therapy
prevention
Prior art date
Application number
AT01271228T
Other languages
English (en)
Inventor
Masao Sugamata
Original Assignee
Tochigi Inst Of Clinical Patho
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tochigi Inst Of Clinical Patho filed Critical Tochigi Inst Of Clinical Patho
Application granted granted Critical
Publication of ATE469642T1 publication Critical patent/ATE469642T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Seal Device For Vehicle (AREA)
AT01271228T 2000-12-18 2001-12-18 Vorbeugungs- oder heilmittel gegen endometriose ATE469642T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000383224A JP4074427B2 (ja) 2000-12-18 2000-12-18 子宮内膜症の予防又は治療薬
PCT/JP2001/011069 WO2002049670A1 (fr) 2000-12-18 2001-12-18 Medicaments preventifs ou remedes pour l'endometriose

Publications (1)

Publication Number Publication Date
ATE469642T1 true ATE469642T1 (de) 2010-06-15

Family

ID=18850916

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01271228T ATE469642T1 (de) 2000-12-18 2001-12-18 Vorbeugungs- oder heilmittel gegen endometriose

Country Status (13)

Country Link
US (2) US7585854B2 (de)
EP (1) EP1352658B1 (de)
JP (1) JP4074427B2 (de)
KR (3) KR100915124B1 (de)
CN (1) CN100379455C (de)
AT (1) ATE469642T1 (de)
AU (2) AU2267602A (de)
CA (1) CA2432177C (de)
DE (1) DE60142308D1 (de)
DK (1) DK1352658T3 (de)
ES (1) ES2343674T3 (de)
HK (1) HK1064944A1 (de)
WO (1) WO2002049670A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799766B2 (en) * 1998-04-08 2010-09-21 Theta Biomedical Consulting & Development Co., Inc. Composition for treating hormonally-dependent cancers
JPWO2005058878A1 (ja) * 2003-12-16 2007-07-12 小野薬品工業株式会社 月経困難症の予防および／または治療剤
US20050220912A1 (en) * 2004-03-30 2005-10-06 Theoharides Theoharis C Anti-inflammatory composition for treating pelvic endometriosis
EP1810690B1 (de) 2004-10-28 2012-01-18 Kyowa Hakko Kirin Co., Ltd. Antikörper gegen IL-5-Rezeptor zur Verwendung in der Behandlung von Endometriose.
US20110092463A1 (en) * 2008-04-07 2011-04-21 Johan Raud Combination for use in the treatment of inflammatory disorders
DE202008009280U1 (de) 2008-07-10 2008-09-11 Beumer Gmbh & Co. Kg Fördervorrichtung mit entgegen der Verfahrrichtung antreibbarer Abschiebeeinrichtung
AU2010260885B2 (en) * 2009-06-17 2015-03-12 Keio University Prophylactic and/or therapeutic agent for dysmenorrhea
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
JP5500051B2 (ja) * 2010-11-22 2014-05-21 富士通セミコンダクター株式会社 強誘電体メモリ
KR102677330B1 (ko) * 2022-01-21 2024-06-20 건양대학교 산학협력단 Tbk1 억제제를 포함하는 태반 염증의 예방 또는 치료용 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID26390A (id) * 1997-12-23 2000-12-21 Schering Corp Komposisi untuk pengobatan pernapasan dan penyakit kulit sekurangnya terdiri dari satu leukotrien antagonis dan satu antihistamin
JP4378580B2 (ja) * 1999-11-02 2009-12-09 ソニー株式会社 インクリボンカセット

Also Published As

Publication number Publication date
US7585854B2 (en) 2009-09-08
DE60142308D1 (de) 2010-07-15
AU2267602A (en) 2002-07-01
KR101064543B1 (ko) 2011-09-14
KR20030062431A (ko) 2003-07-25
KR100915124B1 (ko) 2009-09-03
US20040024016A1 (en) 2004-02-05
EP1352658B1 (de) 2010-06-02
US20090227564A1 (en) 2009-09-10
KR20080077027A (ko) 2008-08-20
KR20090107547A (ko) 2009-10-13
CA2432177C (en) 2011-02-15
AU2002222676B2 (en) 2006-06-01
ES2343674T3 (es) 2010-08-06
DK1352658T3 (da) 2010-09-20
JP2002187855A (ja) 2002-07-05
CN100379455C (zh) 2008-04-09
JP4074427B2 (ja) 2008-04-09
HK1064944A1 (en) 2005-02-08
CN1489475A (zh) 2004-04-14
EP1352658A1 (de) 2003-10-15
EP1352658A4 (de) 2005-01-12
KR101026707B1 (ko) 2011-04-08
WO2002049670A1 (fr) 2002-06-27
CA2432177A1 (en) 2002-06-27

Similar Documents

Publication Publication Date Title
LU92853I2 (fr) Combinaison de rilpivirine ou une forme thérapeutique équivalente qui en dérive telle que protégée par le brevet de base, tel qu'un sel pharmaceutiquement acceptable de rilpivirine, incluant le sel chlorhydrate de rilpivirine et l'emtricitabine
BG108269A (en) Pyrazolopyrimidines as therapeutic agents
DE60122196D1 (de) Synergistische antioxidans-kombination von delta tocols und polyphenolen
PT1235799E (pt) Forma polimorfica de atorvastatina-calcio
BG106586A (en) Pyrazolopyramidines as therapeutic agents
EE200300440A (et) Epotilooni analoogide ja kemoterapeutikumide kombinatsioon proliferatiivsete haiguste raviks
DE60124684D1 (de) Sulfonamido-substituierte verbrückte bicycloalkylderivative
BG108268A (en) Pyrazolopyrimidines as therapeutic agents
CY2013041I2 (el) Φαρμακευτικες συνθεσεις περιλαμβανοντας δεξτρομεθορφανη και κινιδινη για την αγωγη νευρολογικων διαταραχων
BR0215184A (pt) composições farmacêuticas de derivados de taxano oralmente ativos tendo biodisponibilidade aumentada
PT1313489E (pt) Composicoes farmaceuticas para o tratamento de mucosite, estomatite e sindroma de behcet
ATE469642T1 (de) Vorbeugungs- oder heilmittel gegen endometriose
EE200200717A (et) Ravimpreparaat ängistusneuroosi või depressiooni raviks ja piperasiiniderivaadid
DE60016460D1 (de) Verwendungen und zusammenstellungen von nitratestern als sedativa
SE0101932D0 (sv) Pharmaceutical combinations
DE50101827D1 (de) Neue derivate und analoga von galanthamin
ATE326451T1 (de) Chinazolin derivate und therapeutische verwendungen davon
NO20034561D0 (no) Anvendelse av kationiske dekstranderivater for beskyttelse av dosebegrensende organer
ATE374203T1 (de) Therapeutische verbindungen und verfahren
NO20032597L (no) Anvendelse av SARP-1 for behandlingen og/eller forebyggingen av skleroderma
PT1307192E (pt) Candesartan para tratamento da enxaqueca
EE04941B1 (et) Ravimid skisofreenia ennetamiseks ja raviks ning nende valmistamine
DE60139892D1 (de) Makrolidantibiotika für endometriose oder uterusmyome
DE60136706D1 (de) Ycin-acryloyl derivate und antimetabolische mitteln
DE69928685D1 (de) Heilmittel und/oder vorbeugungsmittel gegen fettleibigkeit

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties